Peroxisome proliferator-activated receptor α expression is regulated by estrogen receptor α and modulates the response of MCF-7 cells to sodium butyrate

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 2, 2006, Pages 255-266

  Faddy, Helen M ^a   Robinson, Jodie A ^a   Lee, Won Jae ^a   Holman, Nicola A ^a   Monteith, Gregory R ^a   Roberts Thomson, Sarah J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast; Estrogen receptor; HDAC inhibitors; PPAR; Sodium butyrate

Indexed keywords

BUTYRIC ACID; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BUTYRATES; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; PPAR ALPHA;

MINK CELL FOCUS-FORMING VIRUS;

EID: 27744574062     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2005.09.002     Document Type: Article

References (45)

1. F. Ajamian, A. Salminen, and M. Reeben Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells Neuroscience Letters 365 2004 64 68
2. J. Arts, S. de Schepper, and K. Van Emelen Histone deacetylase inhibitors: From chromatin remodeling to experimental cancer therapeutics Current Medicinal Chemistry 10 2003 2343 2350
3. A. Barron-Gonzalez, and I. Castro Romero Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line Biochemistry and Cell Biology 82 2004 335 342
4. N.J. Bundred Prognostic and predictive factors in breast cancer Cancer Treatment Reviews 27 2001 137 142
5. H.J. Burstein, G.D. Demetri, E. Mueller, P. Sarraf, B.M. Spiegelman, and E.P. Winer Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: A phase II study Breast Cancer Research and Treatment 79 2003 391 397
6. S.E. Campbell, K.A. Mehan, R.J. Tunstall, M.A. Febbraio, and D. Cameron-Smith 17Beta-estradiol upregulates the expression of peroxisome proliferator-activated receptor alpha and lipid oxidative genes in skeletal muscle Journal of Molecular Endocrinology 31 2003 37 45
7. T.H. Chang, and E. Szabo Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung Clinical Cancer Research 8 2002 1206 1212
8. V. Chopin, R.A. Toillon, N. Jouy, and X. Le Bourhis Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells British Journal of Pharmacology 135 2002 79 86
9. S. Cote, A. Rosenauer, A. Bianchini, K. Seiter, J. Vandewiele, and C. Nervi Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells Blood 100 2002 2586 2596
10. F. Dangond, and S.R. Gullans Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate Biochemical and Biophysical Research Communications 247 1998 833 837
11. A. deFazio, Y.E. Chiew, C. Donoghue, C.S. Lee, and R.L. Sutherland Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines Journal of Biological Chemistry 267 1992 18008 18012
12. E. Elstner, C. Muller, K. Koshizuka, E.A. Williamson, D. Park, and H. Asou Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proceedings of the National Academy of Sciences of the United States of America 95 1998 8806 8811
13. L. Fajas, V. Egler, R. Reiter, J. Hansen, K. Kristiansen, and M.B. Debril The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation Developmental Cell 3 2002 903 910
14. M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, and X. Zhang Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment Journal of Biological Chemistry 280 2005 16934 16941
15. K.L. Gearing, A. Crickmore, and J.A. Gustafsson Structure of the mouse peroxisome proliferator activated receptor alpha gene Biochemical and Biophysical Research Communications 199 1994 255 263
16. J.M. Gimble, G.M. Pighetti, M.R. Lerner, X. Wu, S.A. Lightfoot, and D.J. Brackett Expression of peroxisome proliferator activated receptor mRNA in normal and tumorigenic rodent mammary glands Biochemical and Biophysical Research Communications 253 1998 813 817
17. K.A. Graham, and R.N. Buick Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor Journal of Cellular Physiology 136 1988 63 71
18. C.Y. Gui, L. Ngo, W.S. Xu, V.M. Richon, and P.A. Marks Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1 Proceedings of the National Academy of Sciences of the United States of America 101 2004 1241 1246
19. A.K. Hihi, L. Michalik, and W. Wahli PPARs: Transcriptional effectors of fatty acids and their derivatives Cellular and Molecular Life Sciences 59 2002 790 798
20. H. Keller, F. Givel, M. Perroud, and W. Wahli Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements Molecular Endocrinology 9 1995 794 804
21. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
22. C.M. Klinge, B.F. Silver, M.D. Driscoll, G. Sathya, R.A. Bambara, and R. Hilf Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression Journal of Biological Chemistry 272 1997 31465 31474
23. R. Margueron, V. Duong, S. Bonnet, A. Escande, F. Vignon, and P. Balaguer Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens Journal of Molecular Endocrinology 32 2004 583 594
24. S.R. Master, J.L. Hartman, C.M. D'Cruz, S.E. Moody, E.A. Keiper, and S.I. Ha Functional microarray analysis of mammary organogenesis reveals a developmental role in adaptive thermogenesis Molecular Endocrinology 16 2002 1185 1203
25. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
26. M. Meissner, M. Stein, C. Urbich, K. Reisinger, G. Suske, and B. Staels PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation Circulation Research 94 2004 324 332
27. E. Mueller, P. Sarraf, P. Tontonoz, R. Evans, K. Martin, and M. Zhang Terminal differentiation of human breast cancer through PPARγ Molecular Cell 1 1998 465 470
28. C.J. Nicol, M. Yoon, J.M. Ward, M. Yamashida, K. Fukamachi, and J.M. Peters PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis Carcinogenesis 25 2004 1747 1755
29. S.B. Nunez, J.A. Medin, O. Braissant, L. Kemp, W. Wahli, and K. Ozato Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor Molecular and Cellular Endocrinology 127 1997 27 40
30. I. Pineda Torra, T. Claudel, C. Duval, V. Kosykh, J.C. Fruchart, and B. Staels Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor Molecular Endocrinology 17 2003 259 272
31. I. Pineda Torra, Y. Jamshidi, D.M. Flavell, J.C. Fruchart, and B. Staels Characterization of the human PPARalpha promoter: Identification of a functional nuclear receptor response element Molecular Endocrinology 16 2002 1013 1028
32. W. Porter, B. Saville, D. Hoivik, and S. Safe Functional synergy between the transcription factor Sp1 and the estrogen receptor Molecular Endocrinology 11 1997 1569 1580
33. L.H. Puckey, and B.L. Knight Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers Biochemical Journal 366 2002 157 163
34. S.J. Roberts-Thomson Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumor promotion and treatment Immunology and Cell Biology 78 2000 436 441
35. S.J. Roberts-Thomson, and E.G. Snyderwine Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary gland tumors from rats fed high and low fat diets Toxicology Letters 118 2000 79 86
36. E. Saez, J. Rosenfeld, A. Livolsi, P. Olson, E. Lombardo, and M. Nelson PPAR gamma signaling exacerbates mammary gland tumor development Genes and Development 18 2004 528 540
37. H. Sawa, H. Murakami, Y. Ohshima, T. Sugino, T. Nakajyo, and T. Kisanuki Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad Brain Tumor Pathology 18 2001 109 114
38. Y. Sowa, T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, and H. Nomura Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites Biochemical and Biophysical Research Communications 241 1997 142 150
39. R.L. Stephen, M.C.U. Gustafsson, M. Jarvis, R. Tatoud, B.R. Marshall, and D. Knight Activation of peroxisome proliferator-activated receptor {delta} stimulates the proliferation of human breast and prostate cancer cell lines Cancer Research 64 2004 3162 3170
40. K.M. Suchanek, F.J. May, J.A. Robinson, W.J. Lee, N.A. Holman, and G.R. Monteith Peroxisome proliferator-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231 Molecular Carcinogenesis 34 2002 165 171
41. D. Tong, K. Czerwenka, J. Sedlak, C. Schneeberger, I. Schiebel, and N. Concin Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines Breast Cancer Research and Treatment 56 1999 91 97
42. C. Van Lint, S. Emiliani, and E. Verdin The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation Gene Expression 5 1996 245 253
43. D.M. Vigushin, S. Ali, P.E. Pace, N. Mirsaidi, K. Ito, and I. Adcock Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo Clinical Cancer Research 7 2001 971 976
44. X. Wang, and M.W. Kilgore Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells Molecular and Cellular Endocrinology 194 2002 123 133
45. Y. Xie, Q. Yang, and J.W. DePierre The effects of peroxisome proliferators on global lipid homeostasis and the possible significance of these effects to other responses to these xenobiotics: An hypothesis Annals of the New York Academy of Sciences 973 2002 17 25